Primary Myelofibrosis — Trials

Primary Myelofibrosis — Trials · CancerIndex

Clinical trials

Registered studies

242 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 66
Recruiting: 36
Ph III recruiting: 2
Growth YoY: —
Industry share: 30%
Top sponsor: City of Hope Medical Center
Termination share: 38.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06351631	A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)	recruiting	Phase 3	400	Merck Sharp & Dohme LLCINDUSTRY	6	Apr 2, 2026	clinicaltrials
NCT05198960	AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms(AVAJAK)	recruiting	Phase 3	1,308	University Hospital, BrestOTHER	1	Mar 20, 2026